Clinical Trial Update: The Pharmacokinetic, Safety and Tolerability of Tiotropium in Outpatients With Renal Impairment in Comparison to Healthy Subjects [Phase 1]

View source ↗

Summary

This Phase 1 study assesses the pharmacokinetics, safety and tolerability of tiotropium in outpatients with renal impairment compared with healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Insufficiency

Drugs mentioned

• Spiriva (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Renal Insufficiency | Phase 1 | Status: COMPLETED